S1PR1 and Sepsis: In future, APC mutants that lack anticoagulant properties but still enable sphingosine 1 phosphate receptor 1 dependent activation of PAR-1 will be of special clinical interest as they have been shown to reduce sepsis-induced in mice but do not predispose to bleeding complications.